Phase 2 PCCTC Study of Masofaniten in Advanced Prostate Cancer Highlighted by UroToday

November 3, 2023 | Media Relations

Committed to world-class science!

Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.